No Products in the Cart
Current evidence does not support CBD as a reliable performance or recovery aid for athletes: randomized trials on inflammation and muscle recovery mostly show no significant benefit, while a chronic CBD trial found improvements in daytime sleepiness. Athletes also face a real anti-doping contamination risk, and an FDA trial flagged liver enzyme elevations at consumer-representative doses. Below, we break down the trials, the safety data, the anti-doping rules, and what safer use looks like.
TL;DR:
- Trials found that 50 to 300 mg did not improve endurance or perceived exertion, while 5 mg/kg did not reduce inflammation or muscle damage.
- A trial lasting five weeks in adults with hypertension found reduced daytime sleepiness, but overall quality of life did not improve; athletes were not studied.
- In an FDA trial, 5.6% of participants developed significant liver enzyme elevations after 28 days; CBD can also interact with medications processed by the liver.
- Pure CBD is not prohibited, but tested athletes face strict liability for THC contamination; isolates and lab reports for each batch lower risk without eliminating it.
The research on CBD and athletic recovery is thinner than the marketing around it suggests. Most of what exists comes from small randomized trials, often using a crossover design, and the results are mixed at best when it comes to objective markers like inflammation, muscle damage, or restored performance.
One of the clearer data points comes from a randomized crossover study in collegiate athletes, which tested 5 mg/kg of CBD taken before and after a muscle-damaging exercise protocol. The result: no significant reductions in inflammation markers, no meaningful change in muscle damage indicators, no improvement in subjective fatigue, and no measurable restoration of performance compared with a placebo. That is a single-dose, acute-use study, and it is worth distinguishing from chronic supplementation research, where CBD is taken daily over weeks. The two study types ask different questions. Acute dosing tests whether CBD blunts the immediate inflammatory response to a hard training session, while chronic dosing tests whether sustained use shifts something more gradual, like baseline inflammation, sleep, or mood. So far, neither approach has produced consistent, reproducible wins for athletic performance.
Dose matters too, and here the evidence is more specific. A 2025 crossover trial of 25 trained runners tested 50 mg and 300 mg doses of CBD and found no significant impact on perceived exertion, exercise enjoyment, or endurance performance compared with a placebo. That range covers what most consumer tinctures and capsules are designed to deliver, which means the doses people actually buy and use have not shown a performance edge in controlled settings.
Low to moderate acute doses of CBD (50 to 300 milligrams) have not produced measurable improvements in endurance performance or recovery markers in controlled trials. That single data point undercuts a lot of the anecdotal enthusiasm around CBD as a post-workout recovery tool.
Part of the problem is heterogeneity. Trials differ in dose, timing relative to exercise, population (collegiate athletes versus trained runners versus general adults), and which outcomes they measure. A review of CBD in sports contexts noted that while preclinical data suggest anti-inflammatory and anxiolytic properties, well-controlled human data in athletic populations remain sparse and inconsistent, and the cautious consensus leans toward limited current guidance rather than a green light.
Here is a plain summary of where the evidence actually stands:
None of this means CBD does nothing for every athlete in every context. It means the kind of reliable, repeatable benefit you would want before building it into a recovery protocol has not shown up in the trials run so far.
Sleep is where CBD has the most interesting, though still limited, data. A randomized crossover trial in adults with primary hypertension tested five weeks of CBD at doses between 225 and 450 mg and found measurable improvements in excessive daytime sleepiness, along with some gains in fatigue and vitality measures. Overall quality-of-life scores did not shift significantly, which is an important caveat: the benefit showed up on specific, narrow measures rather than across the board.
That trial was not conducted in athletes, and hypertension is a different physiological context than training load or travel fatigue. Still, the signal is worth noting because daytime sleepiness and fatigue are exactly what many active people hope CBD will address, particularly during heavy training blocks or competition travel.
The mechanism behind any sleep benefit is not fully settled. One plausible explanation is indirect: CBD may reduce anxiety or mental arousal in some users, and calmer baseline arousal tends to support better sleep onset and quality. That is a hedged, mechanism-level description rather than a proven pathway, and it is consistent with how the broader sports-focused review frames CBD’s anxiolytic potential as preclinical and still under-studied in controlled human trials.
Findings on sleep quality itself, as opposed to daytime sleepiness, are mixed across the available research. Some trials report modest improvements, others find no change, and few are large enough or long enough to settle the question definitively.
For athletes weighing formulation choices, this has a practical implication:
The most important safety data point for athletes comes from an FDA-sponsored randomized trial that tested CBD at consumer-representative doses, an oral solution of 2.5 mg/kg taken twice daily, totaling roughly 250 to 550 mg per day, over 28 days.
About 5.6% of participants in the FDA trial developed ALT elevations exceeding three times the upper limit of normal, and some met criteria for potential drug-induced liver injury, after 28 days of consumer-representative CBD dosing. The enzyme elevations were dose-dependent and reversible once participants stopped taking CBD, but the finding is significant because the doses tested mirror what is commonly sold in tinctures and capsules, not a pharmaceutical extreme.
This liver effect connects to a second concern: drug interactions. CBD inhibits certain liver enzymes, and the pharmaceutical CBD product Epidiolex has shown dose-dependent liver enzyme elevations along with interactions involving valproate and clobazam, two medications metabolized through pathways CBD affects. The broader implication is that anyone taking medications processed by the liver, including certain pain medications, anti-anxiety drugs, or anticoagulants, should treat CBD as a substance capable of altering how those medications are metabolized, not as an inert add-on.
Animal and developmental research has raised additional caution flags, particularly around use during pregnancy, though this evidence comes from preclinical studies and should not be read as a direct human finding. The prudent takeaway is caution rather than a specific prescriptive claim: pregnant athletes, or those who might become pregnant, should treat CBD as an unresolved risk area and discuss it with a clinician rather than assuming it is automatically safe because it is widely sold.
For anyone using CBD regularly, especially at higher doses, a few monitoring steps make sense:
Pro Tip: If you are on any prescription medication, ask your pharmacist specifically whether it is metabolized by the liver enzymes CBD is known to inhibit, since that conversation catches more interaction risk than a general “is CBD safe” question.
This is the section competitive athletes cannot afford to skim. Pure cannabidiol itself is not on the World Anti-Doping Agency’s prohibited list, but every other cannabinoid, including THC, remains prohibited in-competition. That distinction matters enormously because of how CBD products are actually made.
Athletes are held to a standard called strict liability: if a prohibited substance turns up in your sample, you are responsible for it regardless of how it got there or whether you intended to take it. USADA has warned that athletes face real risk here, because THC contamination in products labeled as pure CBD is common enough to create a significant chance of an anti-doping rule violation, even when a label claims zero THC.
The contamination problem comes down to how CBD is extracted and processed. Hemp plants contain multiple cannabinoids, and extraction methods do not always cleanly separate CBD from trace THC or other cannabinoids. A product can legitimately be marketed and sold as a CBD product while still containing measurable, if small, amounts of THC. For a non-athlete, the anti-doping consequences may not apply, but the product can still raise other concerns. For a tested athlete, even trace amounts can trigger a positive result, because THC contamination can trigger one.
Here are concrete steps to reduce that risk, in order of impact:
A few additional points worth keeping in mind:
If you are a tested athlete, treat every CBD purchase as a decision with regulatory consequences, not just a wellness choice.
If you have weighed the evidence and decided to try CBD, a few practical guardrails make the experience safer and more informative.
On dosing, trial data gives a rough map rather than a precise prescription. Acute, single-dose studies have tested low to moderate ranges around 50 to 300 mg, while the chronic sleep-focused trial used daily doses between 225 and 450 mg over five weeks. Neither range should be read as an optimal dose. They are simply what has been studied, and individual response varies with body weight, metabolism, and what you are hoping to address.
Before buying anything, run through a short product checklist:
On timing, daytime use calls for lower doses and formulations designed to avoid sedation, while sleep-focused use benefits from evening dosing with a formulation built for that purpose. If competition is on the calendar, build in a washout period of at least several days, longer if you are using a higher-dose or full-spectrum product, and avoid any new product or dose change close to competition when you cannot yet predict your own response.
Finally, monitoring matters as much as the product choice. Tell your team medical staff you are using CBD, ask specifically about interactions with any medication you take, and if you are using it chronically or at higher doses, consider baseline and follow-up liver enzyme testing.
Pro Tip: Start with the lowest dose a product offers and keep it steady before adjusting. Individual responses can vary, and the available research does not establish an ideal adjustment schedule.
For a broader look at why athletes reach for CBD in the first place, our primer on CBD and workouts walks through the practical basics before you buy.
We focus on natural, organic CBD products built without additives, and we treat THC-free formulation as a baseline, not a selling point layered on top. That focus matters most in a category where label accuracy varies widely from one seller to the next.
Reading a Certificate of Analysis is the single most useful skill for separating a verified product from a marketing claim. A proper COA shows the full cannabinoid profile, a specific THC result tied to the batch you are holding, and screening results for contaminants including pesticides, heavy metals, and residual solvents left over from extraction. If a product page does not link a batch-specific COA, that is a gap worth asking about before you buy.
Third-party lab testing may help identify contamination, but it does not guarantee that a product is free from prohibited substances. It does not eliminate risk entirely, which is why the washout and isolate-first guidance in the anti-doping section still applies even to well-tested products.
A few habits worth building:
For a full walkthrough, our guide on how to read CBD lab test results breaks down each section of a typical COA line by line.
The evidence does not yet support CBD as a routine recovery or performance tool for athletes. Trials on inflammation, muscle damage, and endurance performance mostly show no consistent benefit, and the sleep data, while more promising, comes from a single trial outside an athletic population.
If you choose to use CBD, prioritize batch-tested isolate products with a verifiable COA and loop in a team clinician before starting, especially if you take other medications. For tested athletes, we lean toward abstinence unless a product has been independently verified and cleared by medical or compliance staff, since strict liability puts the entire burden of risk on you regardless of intent.
Use the lab-guidance resources available to you, ask direct questions of any brand you buy from, and treat CBD as a decision worth real scrutiny rather than a low-stakes wellness purchase.
— Michael
If you are weighing where to start, we built our tincture line around the same daytime-versus-sleep distinction the research points toward. Our 1000mg CBD Tincture Oil Day Drops (30mL) and 1000mg CBD Tincture Oil Day Drops (10mL) are formulated for daytime use without the sedation that can come with heavier night formulas, while our 1000mg CBD Tincture Oil Night Drops (10mL) is built for evening use when sleep support is the goal.
A few guardrails apply no matter which you choose:
Browse our full CBD Tincture Drops collection, or check our CBD products for sleep if nighttime recovery is your main goal.
This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.
Pure CBD itself is not prohibited by the World Anti-Doping Agency, but all other cannabinoids, including THC, remain banned in-competition. The real risk is contamination: USADA has warned that products labeled as pure CBD often contain trace THC, which can trigger a violation under strict liability rules even without intent.
Controlled trials have not shown consistent benefits so far. A randomized crossover study using 5 mg/kg CBD around a muscle-damaging workout found no significant reduction in inflammation, muscle damage markers, or subjective fatigue compared with a placebo.
A randomized crossover trial found that five weeks of CBD improved excessive daytime sleepiness and some fatigue and vitality measures, though overall quality-of-life scores did not change significantly. The findings came from a non-athletic population, so results in active people may vary.
The most notable concern is liver enzyme elevation: an FDA trial found about 5.6% of participants developed significant ALT elevations after 28 days of consumer-representative dosing. CBD can also interact with medications metabolized by the liver, so athletes on other prescriptions should consult a clinician first.
Look for a batch-specific Certificate of Analysis confirming the cannabinoid profile, a non-detect or below-threshold THC result, and screening for contaminants like pesticides and heavy metals. Our guide on how to read CBD lab test results walks through each part of a typical COA.
